Bank of America Corporation »

Neumora Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $258k 15k 17.05

More positions owned by Bank of America Corporation

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Val Etf (IWD)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Bank of America Corporation

Top funds holding Neumora Therapeutics

Softbank Group Corp
MIC Capital Management UK
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Artal Group
EcoR1 Capital
Avidity Partners Management
Citadel Advisors
Hillhouse Capital Advisors
OrbiMed Advisors
Goldman Sachs Group
Logos Global Management
Vanguard Group
Addis & Hill
Schonfeld Strategic Advisors
Pier Capital

View all funds holding Neumora Therapeutics